Mrv0541 01121421192D 15 15 0 0 0 0 999 V2000 9.7846 -4.2592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7846 -5.0842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.2135 -4.2592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.2135 -5.0842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4991 -3.8468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.3569 -3.8468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.3569 -3.0218 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 12.6424 -4.2592 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 11.9279 -3.8468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.0713 -4.2592 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 9.0701 -5.4967 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10.4991 -5.4967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4991 -6.3217 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 12.2299 -4.9737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.0549 -4.9737 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 0 0 0 11 2 1 0 0 0 0 9 3 1 0 0 0 0 4 3 1 0 0 0 0 1 5 1 0 0 0 0 5 3 2 0 0 0 0 2 12 1 0 0 0 0 12 4 2 0 0 0 0 6 7 2 0 0 0 0 6 8 1 0 0 0 0 10 6 1 0 0 0 0 8 9 1 0 0 0 0 12 13 1 0 0 0 0 8 14 1 0 0 0 0 8 15 1 1 0 0 0 M END > T3D3577 > t3db > C[C@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O > InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1 > CJCSPKMFHVPWAR-JTQLQIEISA-N > C10H13NO4 > 211.2145 > 211.084457909 > 5 > 20.73358916638329 > 1 > 4 > 0 > 0 > (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid > -2.02 > -1.3594803166154474 > -1.97 > 0 > 1 > 0 > 9.136101334364048 > 1.7286926215142575 > 9.847735184725035 > 103.78 > 53.791399999999996 > 3 > 1 > 2.26e+00 g/l > methyldopa > 0 > T3D3577 > Methyldopa > 555-30-6 > (S)-(-)-alpha-Methyldopa; 3-Hydroxy-alpha-methyl-L-tyrosine; Aldomet; Aldometil; Aldomin; Alpha medopa; alpha-Methyl dopa; alpha-methyl-L-dopa; Alphamethyldopa; AMD; Dopamet; Hypolag; L-alpha-Methyldopa; L-Methyl Dopa; Medomet; Medopren; Novomedopa; Nu-Medopa > Organic Compound; Amine; Drug; Food Toxin; Sympatholytic; Antihypertensive Agent; Metabolite; Synthetic Compound; Adrenergic alpha-2 Receptor Agonist $$$$